-Reuters
SIGA Receives Approval From The FDA For Intravenous Formulation Of TPOXX
SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the U.S. Food and Drug Administration (FDA) approved the intravenous